A

Avenue Therapeutics

D
ATXI
USD
-0.03
(-1.3393%)
Market Closed
155.000
حجم التداول
-19.76
الربح لكل سهم
-
العائد الربحي
0.058965
P/E
3,163,296.76
حجم السوق
اليوم
-1.3393%
1 اسبوع
-8.866%
1 شهر
4.739%
6 اشهر
-46.229%
12 اشهر
-87.514%
بداية السنة
-81.933%
كل الوقت
0%

Title:
Avenue Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
هل تحتاج مساعدة او لديك استفسار؟